Aysegul Ors (A Ors)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Breast Cancer Cells

Microbial Community

Gene Expression

Top Venues

Disease models & mechanisms

Cancer research

Nucleic acids research

This page only lists publications with an associated author ORCID identifier.

Publications

Ateequllah Hayat, Edward Philip Carter, Hamish W King, Aysegul Ors, Aaron Reid Doe, Saul A Teijeiro, Sarah Charrot, Susana Godinho, Pedro Cutillas, Hisham Mohammed, Richard Philip Grose, Gabriella Ficz
Low HER2 expression in normal breast epithelium enables dedifferentiation and malignant transformation via chromatin opening. Disease models & mechanisms 16 (2) (2023)
Ateequllah Hayat, Edward Philip Carter, Hamish W King, Aysegul Ors, Aaron Reid Doe, Saul A Teijeiro, Sarah Charrot, Susana Godinho, Pedro Cutillas, Hisham Mohammed, Richard Philip Grose, Gabriella Ficz
Low HER2 expression in normal breast epithelium enables dedifferentiation and malignant transformation via chromatin opening. Disease models & mechanisms 16 (2) (2023)
Ateequllah Hayat, Edward Philip Carter, H W King, Aysegul Ors, Aaron Reid Doe, S A Teijeiro, S Charrot, S Godinho, P Cutillas, H Mohammed, Richard Philip Grose, Gabriella Ficz
Low HER2 enables dedifferentiation and transformation of normal breast epithelial cells via chromatin opening. Disease models & mechanisms (2023)
Ateequllah Hayat, Edward Philip Carter, Hamish W King, Aysegul Ors, Aaron Reid Doe, Saul A Teijeiro, Sarah Charrot, Susana Godinho, Pedro Cutillas, Hisham Mohammed, Richard Philip Grose, Gabriella Ficz
Low HER2 expression in normal breast epithelium enables dedifferentiation and malignant transformation via chromatin opening. Disease models & mechanisms 16 (2) (2023)
Ateequllah Hayat, Edward Philip Carter, Hamish W King, Aysegul Ors, Aaron Reid Doe, Saul A Teijeiro, Sarah Charrot, Susana Godinho, Pedro Cutillas, Hisham Mohammed, Richard Philip Grose, Gabriella Ficz
Low HER2 expression in normal breast epithelium enables dedifferentiation and malignant transformation via chromatin opening. Disease models & mechanisms 16 (2) (2023)
Ateequllah Hayat, Edward Philip Carter, Hamish W King, Aysegul Ors, Aaron Reid Doe, Saul A Teijeiro, Sarah Charrot, Susana Godinho, Pedro Cutillas, Hisham Mohammed, Richard Philip Grose, Gabriella Ficz
Low HER2 expression in normal breast epithelium enables dedifferentiation and malignant transformation via chromatin opening. Disease models & mechanisms 16 (2) (2023)
Aysegul Ors, Alex Daniel Chitsazan, Aaron Reid Doe, Ryan M Mulqueen, Cigdem Ak, Yahong Wen, Syber Haverlack, Mithila Handu, Spandana Naldiga, Joshua C Saldivar, Hisham Mohammed
Estrogen regulates divergent transcriptional and epigenetic cell states in breast cancer. Nucleic acids research 50 (20) (2022)
Agostina Nardone, Xintao Qiu, Sándor Spisák, Zsuzsanna Nagy, Ariel Feiglin, Avery Feit, Gabriella Cohen, Yingtian Xie, Alba Font-Tello, Cristina Guarducci, Francisco Hermida-Prado, Sudeepa Syamala, Klothilda Lim, Miguel Munoz Gomez, Matthew Pun, MacIntosh Grant Cornwell, Weihan Liu, Aysegul Ors, Hisham Mohammed, Paloma Cejas, Jane B Brock, Matthew L Freedman, Eric P Winer, Xiaoyong Fu, Rachel Schiff, Henry W Long, Otto Metzger Filho, Rinath M Jeselsohn
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer. Cancer research 82 (20) (2022)